|
|
|
|
| LEADER |
01562nam a2200349 u 4500 |
| 001 |
10047127 |
| 003 |
upatras |
| 005 |
20210303084156.0 |
| 008 |
030527s2000 uk eng |
| 020 |
|
|
|a 0471627445
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a 615.19
|
| 245 |
1 |
0 |
|a From genome to therapy
|b integrating new technologies with drug development
|c [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode]
|
| 260 |
|
|
|a Chichester
|b John Wiley & Sons, Ltd.
|c 2000
|
| 300 |
|
|
|a viii, 165 p.
|b fig., tab.
|c 24 cm.
|
| 490 |
0 |
|
|a Novartis Foundation Symposium
|v 229
|
| 500 |
|
|
|a Symposium on From genome to therapy: integrating new technologies with drug development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 650 |
|
4 |
|a Φάρμακα
|x Κατασκευή
|9 1265
|
| 650 |
|
4 |
|a Φαρμακευτική τεχνολογία
|9 36666
|
| 700 |
1 |
|
|a Bock, Gregory
|4 edt
|9 38351
|
| 700 |
1 |
|
|a Cohen, Dalia
|4 edt
|9 38352
|
| 700 |
1 |
|
|a Goode, Jamie
|4 edt
|9 38353
|
| 710 |
2 |
|
|a Novartis Foundation
|9 38354
|
| 760 |
1 |
|
|a Novartis Foundation Symposium
|g 229
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΒΣ1
|k ΑΣΧΞ
|h 615.19 B
|m 070726
|p 025000109992
|t 1
|
| 856 |
4 |
|
|u http://www.loc.gov/catdir/toc/onix05/00043348.html
|
| 942 |
|
|
|2 ddc
|c BK15
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_190000000000000_B
|7 0
|9 37298
|a LISP
|b LISP
|c BSC
|d 2016-04-24
|i 070726
|l 0
|o 615.19 B
|p 025000109992
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
| 998 |
|
|
|c ΒΑΣΙΛΕΙΟΥ
|d 2003-06
|
| 999 |
|
|
|c 23963
|d 23963
|
